 receptor
blockers for the sole purpose of reducing the risk of AAA
expansion and rupture.
Level of recommendation

2 (Weak)

Quality of evidence

C (Low)

We suggest not administering beta blocker therapy for the
sole purpose of reducing the risk of AAA expansion and
rupture.
Level of recommendation

1 (Strong)

Quality of evidence

B (Moderate)

Timing of intervention
A patient with a known AAA or pulsatile mass on
abdominal examination who presents without